Streetbeat News

Analyst Ratings

ORCL

JP Morgan analyst Mark Murphy has downgraded Oracle (NYSE:ORCL) from Overweight to Neutral and lowered the price target from $112 to $100.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:13 pm

IMGN

JP Morgan analyst Daniel Wolle has upgraded Immunogen (NASDAQ:IMGN) from Neutral to Overweight and raised the price target from $9 to $22.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:09 pm

SGHT

B of A Securities analyst Bob Hopkins has downgraded Sight Sciences (NASDAQ:SGHT) from Neutral to Underperform and lowered the price target from $10 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:08 pm

BALL

Credit Suisse analyst Curt Woodworth has downgraded Ball Corporation (NYSE:BALL) from Outperform to Neutral and lowered the price target from $65 to $58.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:06 pm

SEE

Credit Suisse analyst Curt Woodworth has upgraded Sealed Air (NYSE:SEE) from Neutral to Outperform, but lowered the price target from $59 to $47.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:06 pm

ORCL

Oracle Corporation (NYSE:ORCL) released mixed Q1 results with a revenue of $12.45 billion, up 9% YoY, slightly below the market estimate of $12.46 billion. Adjusted EPS was $1.19, beating the consensus estimate of $1.15. Several analysts adjusted their price targets for Oracle following the results. The company offers an annual dividend yield of 1.27%, which equates to a quarterly dividend of $0.40 per share. To earn $500 per month from dividends, an investment of approximately $411,038 or around 3,750 shares is needed.

Portfolio Pulse from Lisa Levin

September 13, 2023 | 1:05 pm

OI

Credit Suisse analyst Curt Woodworth has downgraded O-I Glass (NYSE:OI) from Outperform to Neutral, while raising the price target from $21 to $22.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:05 pm

K

RBC Capital analyst Nik Modi has reiterated a 'Sector Perform' rating on Kellogg (NYSE:K) and maintained a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:02 pm

SGHT

Morgan Stanley analyst Cecilia Furlong maintains an Equal-Weight rating on Sight Sciences (NASDAQ:SGHT) and lowers the price target from $8.4 to $4.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:01 pm

VC

Over the last quarter, Visteon (NASDAQ:VC) has received mixed analyst ratings, with 1 somewhat bullish, 3 indifferent, and 3 somewhat bearish. In the last 3 months, 7 analysts have offered 12-month price targets for Visteon, with an average price target of $151.29, up by 2.45% from the previous average of $147.67.

Portfolio Pulse from Benzinga Insights

September 13, 2023 | 1:01 pm